Objective: To assess the feasibility of using an at-home multilevel pregnancy test (MLPT) and interactive voice response (IVR) call-in system for remote follow-up of medical abortion. 
| INTRODUCTION
Most women who have a medical abortion using mifepristone (taken in a clinic or at home) and misoprostol (usually taken at home) experience successful pregnancy termination without the need for further care. Nonetheless, service delivery practices often require a follow-up visit to determine the outcome.
The need for multiple clinic visits is frequently reported as a reason why women do not select medical abortion when offered the choice of surgical or medical methods. 2, 3 Furthermore, many women do not return for clinic visits in settings where in-person follow-up is standard practice. 4, 5 Consequently, guidelines for induced abortion have started to move away from strict recommendations of inperson follow-up and toward alternative service delivery options. 6, 7 Researchers are now working to identify follow-up approaches that balance women's preference for a reduced number of clinic visits with the need for healthcare providers to document the outcomes of medical abortion.
2,8,9
The multilevel pregnancy test (MLPT) is a promising tool for streamlining the follow-up of medical abortion. [10] [11] [12] [13] This semiquantitative test comprises a urine dipstick that provides bracketed ranges of human chorionic gonadotropin (hCG) levels. Most studies assessing MLPTs in abortion care have used a two-test before-andafter approach, whereby hCG range is determined both at baseline (i.e. before administration of mifepristone and misoprostol) and at 7-14 days later. [10] [11] [12] [13] If the hCG range has decreased during this time frame, women and healthcare providers can be confident of no ongoing pregnancy. By contrast, no decrease in hCG range indicates the need for further clinical evaluation, although this result does not necessarily mean that the pregnancy remains ongoing. A meta-analysis showed that MLPTs offer 100.0% predictive value (95% confidence interval 93.3%-100.0%) to detect ongoing pregnancy after early medical abortion (≤63 days of pregnancy). 14 Research conducted in various contexts shows that women find the MLPT easy to use and many prefer this home-based method to in-clinic follow-up. 10, 11, 13 Most studies that assessed MLPT for at-home use required partic- The aim of the present study was to determine the feasibility of implementing a technology-based remote approach to follow-up of medical abortion using an at-home MLPT, with the results reported by women to an IVR system.
| MATERIALS AND METHODS
The present prospective pilot study was conducted at Hospital City. All participants provided written informed consent.
Women were eligible to participate if they were having medical abortion with 200 mg of oral mifepristone (taken in the clinic) and 800 μg of buccal misoprostol (taken at home); had a pregnancy of 70 days or less (as determined by ultrasonography); were willing to take the MLPT and call the IVR system; and were willing to return to the clinic for the in-person follow-up visit. Women without access to a telephone or without transportation to return to the clinic were excluded from the study.
All participants took a baseline MLPT at the clinic and were then administered mifepristone. Upon calling the IVR system, recorded voice prompts instructed participants to enter their unique study identification codes. They were also asked to provide the following information from the instruc- The data were analyzed using SPSS version 19.0 (IBM, Armonk, NY, USA). The responses entered into the IVR system were match-merged to the SPSS database using the each participant's unique identification code. The outcome of medical abortion as indicated by the reported athome MLPT result versus the in-clinic follow-up evaluation was compared. After protocol development and ethical approval of the present study, the MLPT using the dBest test was shown to be potentially less predictive of ongoing pregnancy among women having medical abortion after 63 days compared to pregnancies greater than 63 days.
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Consequently, the results were stratified by duration of pregnancy from last menstrual period (≤63 days, 64-70 days). To determine how eliminating in-clinic follow-up visits might affect the provision of contraception after medical abortion, the proportion of women receiving family planning methods at the initial and follow-up clinic visits was evaluated. Proportions were also calculated for the acceptability questions, including the participants' preference for follow-up and the aspects that they liked most and least about the IVR system.
| RESULTS
The baseline characteristics of the 200 women enrolled in the present study are shown in Table 1 . Only 13 (6.5%) had education level below secondary.
The flow of participants enrolled in the present study is outlined in Figure 1 . In all, 37 (18.5%) of the 200 participants were eventu- 
| DISCUSSION
The present feasibility study showed that use of an at-home MLPT and suggested that 93% of women who used the MLPT plus IVR system approach to follow-up could avoid a second clinic visit after medical abortion initiated at less than 63 days after last menstrual period.
Generally, there is increasing recognition that in-person follow-up is unnecessary for most women who have medical abortion 6, 7 ; however, both women and providers would likely welcome a tool to provide assurance that the procedure is complete and to maintain a link to healthcare services. The current data suggested that both of these functions can be served by an approach that pairs the use of MLPTs with an IVR telephone system. Although the present study found this model to be acceptable to most of the participants, some indicated they would prefer direct contact with clinic staff, either face-to-face or by telephone. The range of preferences reported in the present study demonstrated a clear need to offer women a range of choices for care after medical abortion. Given the growing use of telemedicine technologies for induced abortion 17 and other areas of health care, 15, [18] [19] [20] integrating IVR technology into medical abortion care could be an acceptable way to make at-home follow-up a reality.
The current findings confirmed previous research showing that
MLPTs are effective for identifying women with no ongoing pregnancy following medical abortion initiated on or before 63 days from the last menstrual period.
14 The present study also corroborated published evidence suggesting that MLPT has potentially lower accuracy for detecting ongoing pregnancy following medical abortion performed after 63 days.
12
At present, several barriers exist to making follow-up by MLPT plus the IVR system a reality for most women who have medical abortion.
First, the MLPT is commercially available in just a few countries and, despite efforts to register products in additional settings, it is currently uncertain when and where the test will become available. However, an IVR system could be used alongside other tools for home-based follow-up, such as low-sensitivity urinary pregnancy tests. ing contraception provision at the initial clinic visit is advantageous, as many women might not return for a second visit, even when it is requested that they should do so.
Limitations of the present study included the small sample size; no ongoing pregnancies occurred among the women who had a medical abortion on or before 63 days, and we were thus unable to determine how the MLPT and IVR approach would perform in these infrequent cases. However, previous research shows that the MLPT is accurate in detecting ongoing pregnancy following medical abortion within that time frame, 12, 14 and it is unlikely that use of the IVR system would deter women from seeking additional care if the MLPT results indicated it was necessary. In addition, it was not possible to determine whether the participants had accurately reported their follow-up MLPT results because women read the test and entered results into the IVR system at home and these data were not validated at the time of interpretation by the IVR system. Nevertheless, the participants were asked to record the follow-up MLPT results on the instruction card; these results largely correlated with those reported to the IVR system (data not shown).
In conclusion, as mounting evidence supports the use of MLPTs for follow-up of medical abortion, it has become necessary to consider how this simple tool might be integrated into clinical care, especially once MLPTs are made widely available. The present study provided evidence to support the feasibility of an approach comprising the use of MLPTs and IVR technology after early medical abortion. Such strategies provide important steps to reducing the unnecessary hurdles women face in using this simple and safe method of induced abortion.
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T A B L E 3 Experiences of using the interactive voice response telephone system and preferences for follow-up care among the participants (n=163). Values are given as number (percentage). b Responses were not mutually exclusive and participants could mention more than one aspect that they liked most. Five or fewer participants also reported that they most liked the following: step-by-step instructions (n=5); helped to explain the results (n=5); slow (n=4); good service and/or good care (n=4); repeated questions (n=2); and could do it at home and/or did not need to return to the clinic (n=1). c 85 (52.1%) women said there was nothing they disliked most about the IVR system. Responses were not mutually exclusive and participants could mention more than one aspect that they liked least. Five or fewer participants also reported that they least liked the following: not clear and/or did not understand the IVR prompts(n=4); technical problems (n=4); operator's voice (n=3); repetitive (n=3); did not trust the result (n=2); too fast (n=1); could not ask questions (n=1); too many options for responses (n=1); did not know when the service was available (n=1); and too long (n=1).
